Belgium boasts a strong healthcare system with a good reputation, but access to innovation remains a concern. Roche invests heavily in research and development (R&D), but…
In Conversation
Greece is the second and third largest patient enroller globally for two of GSK’s clinical trials in lung cancer and multiple myeloma respectively, drawing on the…
There is trust in [Colombia], and regardless of which shade of government is in power, we will not stop investing in its future
EU Recovery and Resilience Funding (RRF) is coming online, creating an opportunity for Greece to improve its healthcare system, which we are fully aligned with and…
The Greek healthcare system is in the initial stages of an important restructuring and reform, and there will be many opportunities going forward
It is a point of national pride to be able to assist Greek firms to enter prestigious international markets
Due to the 2008 crisis and its effects on the [Greek] pharmaceutical market, the company has given an increased focus to exports over the last few…
Having a Latin American dimension, not only in the business but also in management, is a catalyst for sustainability
My team and I are constantly focused on understanding needs throughout the entire patient journey, identifying where areas for improvement exist, and how we can keep…
The pandemic has given us the opportunity to reclaim our spot in the APIs market and not repeat the mistakes of the past
Despite the projected GDP growth since 2020 in most of [LatAm], existing healthcare budgets and reforms are no longer adept at addressing the unmet needs, creating…
